Pharmaceutical

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.

Feb 20, 2024 - 18:00
RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.
Read the original article

Tags:

Previous Article

RioDerm-004 by Rion for Fistula: Likelihood of Approval

Next Article

SY-001 by CellOrigin Technology (Hangzhou) for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare official insists drug price negotiation will consider value of drugs

STAT+: Medicare official insists drug price negotiation...

Apr 25, 2023

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition

J&J asserts its place in atopic dermatitis space with Y...

Jul 12, 2024

Putting compliance and quality at the heart of pharmaceutical supply chains​

Putting compliance and quality at the heart of pharmace...

Nov 8, 2023